Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SOUN vs GSK✓SelectedUSD · GSKSOUN vs GSK performance historyLatest closeAs of-10.31%11/20
Stock and ETF performance explorer

SOUN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-65.2%
GSK return
+27.1%
Excess return
-92.3%
Maximum drawdown
-93.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-10.3%-0.1%-10.2%-10.3%
7D-25.2%-5.3%-19.9%-25.0%
30D-43.4%-3.7%-39.7%-43.3%
3M-62.6%-7.3%-55.3%-62.4%
6M-69.1%-4.2%-64.9%-69.1%
YTD-73.8%+0.9%-74.7%-73.9%
1Y-76.9%+7.3%-84.2%-77.1%
3Y+17.6%+52.7%-35.2%+16.2%
All-65.2%+27.1%-92.3%-69.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling